|
|
||||||||
,

,
,
,
,
Divisions of
*
Cardiovascular Medicine and
Clinical Pharmacology, and Departments of
Medicine and
Pharmacology, Vanderbilt University, Nashville, TN 37232; and
¶ Department of Drug Research and Pharmacological Sciences, CV Therapeutics, Inc., Palo Alto, CA 94304
Adenosine provokes bronchoconstriction in asthmatics through acute activation of mast cells, but its potential role in chronic inflammation has not been adequately characterized. We hypothesized that adenosine up-regulates Th2 cytokines in mast cells, thus promoting IgE synthesis by B lymphocytes. We tested this hypothesis in human mast cells (HMC-1) expressing A2A, A2B, and A3 adenosine receptors. The adenosine analog 5'-N-ethylcarboxamidoadenosine (NECA) (10 µM) increased mRNA expression of IL-1
, IL-3, IL-4, IL-8, and IL-13, but not IL-2 and IFN-
. Up-regulation of IL-4 and IL-13 was verified using RT-PCR and ELISA; 10 µM NECA increased IL-13 concentrations in HMC-1 conditioned medium 28-fold, from 7.6 ± 0.3 to 215 ± 4 pg/ml, and increased IL-4 concentrations 6-fold, from 19.2 ± 0.1 to 117 ± 2 pg/ml. This effect was mediated by A2B receptors because neither the selective A2A agonist 2-p-(2-carboxyethyl)phenethylamino-NECA nor the selective A3 agonist N6-(3-iodobenzyl)-N-methyl-5'-carbamoyladenosine reproduced it, and the selective A2B antagonist 3-isobutyl-8-pyrrolidinoxanthine prevented it. Constitutive expression of CD40 ligand on HMC-1 surface was not altered by NECA. Human B lymphocytes cocultured for 12 days with NECA-stimulated HMC-1 produced 870 ± 33 pg IgE per 106 B cells, whereas lymphocytes cocultured with nonstimulated HMC-1, or cultured alone in the absence or in the presence of NECA, produced no IgE. Thus, we demonstrated induction of IgE synthesis by the interaction between adenosine-stimulated mast cells and B lymphocytes, and suggest that this mechanism is involved in the amplification of the allergic inflammatory responses associated with asthma.
Related articles in The JI:
This article has been cited by other articles:
![]() |
S. Ryzhov, R. Zaynagetdinov, A. E. Goldstein, S. V. Novitskiy, M. M. Dikov, M. R. Blackburn, I. Biaggioni, and I. Feoktistov Effect of A2B Adenosine Receptor Gene Ablation on Proinflammatory Adenosine Signaling in Mast Cells J. Immunol., June 1, 2008; 180(11): 7212 - 7220. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fernandez, S. Trzaska, T. Wilder, L. Chiriboga, M. R. Blackburn, B. N. Cronstein, and E. S. L. Chan Pharmacological Blockade of A2A Receptors Prevents Dermal Fibrosis in a Model of Elevated Tissue Adenosine Am. J. Pathol., June 1, 2008; 172(6): 1675 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Hanania Targeting Airway Inflammation in Asthma: Current and Future Therapies Chest, April 1, 2008; 133(4): 989 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ryzhov, R. Zaynagetdinov, A. E. Goldstein, S. V. Novitskiy, M. R. Blackburn, I. Biaggioni, and I. Feoktistov Effect of A2B Adenosine Receptor Gene Ablation on Adenosine-Dependent Regulation of Proinflammatory Cytokines J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 694 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mohsenin, T. Mi, Y. Xia, R. E. Kellems, J.-F. Chen, and M. R. Blackburn Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L753 - L761. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Blackburn A role for neural pathways in adenosine-induced bronchoconstriction Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L22 - L24. [Full Text] [PDF] |
||||
![]() |
G. Burnstock Physiology and Pathophysiology of Purinergic Neurotransmission Physiol Rev, April 1, 2007; 87(2): 659 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Mustafa, A. Nadeem, M. Fan, H. Zhong, L. Belardinelli, and D. Zeng Effect of a Specific and Selective A2B Adenosine Receptor Antagonist on Adenosine Agonist AMP and Allergen-Induced Airway Responsiveness and Cellular Influx in a Mouse Model of Asthma J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1246 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. J. Young, C.-X. Sun, C. M. Evans, B. F. Dickey, and M. R. Blackburn A3 Adenosine Receptor Signaling Contributes to Airway Mucin Secretion after Allergen Challenge Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 549 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhong, Y. Wu, L. Belardinelli, and D. Zeng A2B Adenosine Receptors Induce IL-19 from Bronchial Epithelial Cells, Resulting in TNF-{alpha} Increase Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 587 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ryzhov, A. E. Goldstein, I. Biaggioni, and I. Feoktistov Cross-Talk between Gs- and Gq-Coupled Pathways in Regulation of Interleukin-4 by A2B Adenosine Receptors in Human Mast Cells Mol. Pharmacol., August 1, 2006; 70(2): 727 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Chunn, A. Mohsenin, H. W. J. Young, C. G. Lee, J. A. Elias, R. E. Kellems, and M. R. Blackburn Partially adenosine deaminase-deficient mice develop pulmonary fibrosis in association with adenosine elevations Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L579 - L587. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Lin and J. A. Boyce IL-4 Regulates MEK Expression Required for Lysophosphatidic Acid-Mediated Chemokine Generation by Human Mast Cells J. Immunol., October 15, 2005; 175(8): 5430 - 5438. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Chunn, J. G. Molina, T. Mi, Y. Xia, R. E. Kellems, and M. R. Blackburn Adenosine-Dependent Pulmonary Fibrosis in Adenosine Deaminase-Deficient Mice J. Immunol., August 1, 2005; 175(3): 1937 - 1946. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |